Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.12
-0.05 (-0.70%)
Apr 29, 2026, 11:54 AM EDT - Market open
Unicycive Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 29.2 | 26.14 | 9.7 | 0.46 | 16.58 | Upgrade
|
| Short-Term Investments | 12.07 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 41.27 | 26.14 | 9.7 | 0.46 | 16.58 | Upgrade
|
| Cash Growth | 57.87% | 169.48% | 2032.09% | -97.26% | - | Upgrade
|
| Prepaid Expenses | 6.52 | 3.87 | 3.37 | 2.03 | 1.71 | Upgrade
|
| Other Current Assets | 1.17 | 0.94 | 0.33 | 0.16 | 0.13 | Upgrade
|
| Total Current Assets | 48.96 | 30.95 | 13.4 | 2.64 | 18.41 | Upgrade
|
| Property, Plant & Equipment | 0.17 | 0.72 | 0.79 | 0.17 | 0.33 | Upgrade
|
| Total Assets | 49.14 | 31.67 | 14.19 | 2.82 | 18.74 | Upgrade
|
| Accounts Payable | 0.38 | 1.06 | 0.84 | 0.89 | 0.74 | Upgrade
|
| Accrued Expenses | 1.52 | 3.56 | 3.23 | 2.24 | 1.21 | Upgrade
|
| Current Portion of Leases | 0.12 | 0.56 | 0.33 | 0.16 | 0.15 | Upgrade
|
| Other Current Liabilities | 16.92 | 18.94 | 13.13 | - | - | Upgrade
|
| Total Current Liabilities | 18.94 | 24.12 | 17.53 | 3.28 | 2.11 | Upgrade
|
| Long-Term Leases | - | 0.12 | 0.47 | - | 0.16 | Upgrade
|
| Total Liabilities | 18.94 | 24.24 | 18 | 3.28 | 2.26 | Upgrade
|
| Common Stock | 0.02 | 0.01 | 0.04 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 158 | 108.69 | 60.7 | 33.52 | 32.41 | Upgrade
|
| Retained Earnings | -127.83 | -101.27 | -64.54 | -34 | -15.94 | Upgrade
|
| Comprehensive Income & Other | -0 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 30.2 | 7.43 | -3.81 | -0.47 | 16.48 | Upgrade
|
| Total Liabilities & Equity | 49.14 | 31.67 | 14.19 | 2.82 | 18.74 | Upgrade
|
| Total Debt | 0.12 | 0.68 | 0.79 | 0.16 | 0.31 | Upgrade
|
| Net Cash (Debt) | 41.15 | 25.46 | 8.91 | 0.3 | 16.27 | Upgrade
|
| Net Cash Growth | 61.63% | 185.82% | 2869.33% | -98.16% | - | Upgrade
|
| Net Cash Per Share | 2.59 | 3.80 | 3.63 | 0.20 | 13.94 | Upgrade
|
| Filing Date Shares Outstanding | 25.24 | 11.97 | 3.48 | 1.52 | 1.5 | Upgrade
|
| Total Common Shares Outstanding | 22.11 | 11.38 | 3.48 | 1.52 | 1.5 | Upgrade
|
| Working Capital | 30.02 | 6.83 | -4.14 | -0.64 | 16.31 | Upgrade
|
| Book Value Per Share | 1.37 | 0.65 | -1.10 | -0.31 | 10.99 | Upgrade
|
| Tangible Book Value | 30.2 | 7.43 | -3.81 | -0.47 | 16.48 | Upgrade
|
| Tangible Book Value Per Share | 1.37 | 0.65 | -1.10 | -0.31 | 10.99 | Upgrade
|
| Machinery | 0.07 | 0.07 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Leasehold Improvements | 0.07 | 0.05 | 0.02 | 0.02 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.